| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a94b638de93e386b2b965fc76300cd85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3e4505832b110b5e5e4f9bd722280ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e29526f284c0155fd79806c9dd5a1c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4869821db28b27324c6077585a6ff62a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 |
| filingDate |
2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025c99634dc52599caf188cf701dec03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deff1189a68d80093928f35204bb3cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_416a606834d61fe309f13435d08afaa0 |
| publicationDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012295849-A1 |
| titleOfInvention |
Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders |
| abstract |
The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders. |
| priorityDate |
2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |